SCHEMBL25914845

SCHEMBL25914845

COc1cc2ccc3c4cc(OC)c(OC)cc4c(=O)n(CCN(C)C)c3c2cc1O

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 8/20 0.87
JAK2 O60674 2/20 0.48
JAK1 P23458 2/20 0.48
TYK2 P29597 2/20 0.48
JAK3 P52333 2/20 0.48
EGFR P00533 5/20 0.39
KDM4E B2RXH2 2/20 0.37
GAA P10253 2/20 0.37
RECQL P46063 2/20 0.37
MCL1 Q07820 2/20 0.37
ABL1 P00519 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.37
APEX1 P27695 1/20 0.37
BLM P54132 1/20 0.37
CDK5 Q00535 1/20 0.37
RIN1 Q13671 1/20 0.37
CDK5R1 Q15078 1/20 0.37
SAE1 Q9UBE0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25914841 0.97 TDP1 (0.85) TDP1JAK2JAK1TYK2JAK3
SCHEMBL25914848 0.94 TDP1 (0.85) TDP1JAK2JAK1TYK2JAK3
SCHEMBL25914833 0.93 TDP1 (1.00) TDP1JAK2JAK1TYK2JAK3
SCHEMBL25914840 0.88 TDP1 (1.00) TDP1JAK2JAK1TYK2JAK3
SCHEMBL12523086 0.88 TDP1 (1.00) TDP1JAK2JAK1TYK2JAK3
SCHEMBL25914830 0.85 TDP1 (1.00) TDP1JAK2JAK1TYK2JAK3
SCHEMBL25914847 0.84 TDP1 (1.00) TDP1JAK2JAK1TYK2JAK3
SCHEMBL25914824 0.83 TDP1 (0.80) TDP1JAK2JAK1TYK2JAK3
SCHEMBL30483855 0.82 TDP1 (0.96) TDP1JAK2JAK1TYK2JAK3
SCHEMBL21630105 0.82 TDP1 (0.96) TDP1JAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219895-A1 OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (TOP1) AND TYROSYL-DNA PHOSPHODIESTERASE 1 (TDP1) SHENZHEN XUHUA BIOTECH CO. LTD. (CN) 2023-07-13 US disclosed
US-20230219895-A1 OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (TOP1) AND TYROSYL-DNA PHOSPHODIESTERASE 1 (TDP1) SHENZHEN XUHUA BIOTECH CO. LTD. (CN) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219895-A1 OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (TOP1) AND TYROSYL-DNA PHOSPHODIESTERASE 1 (TDP1) TDP1, TOP1, TOP2A TDP1 1/4885JAK2 3608/4885JAK1 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.